Report Detail
Global Brucellosis Vaccines Market Growth 2019-2024
- RnM2996502 |
- 21 February, 2019 |
- Global |
- 165 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
The classification of Brucellosis Vaccines includes S19 Vaccine, RB51 Vaccine Strain and Other. And the proportion of S19 Vaccine in 2016 is about 86%, and the proportion is stable from 2012 to 2016.
Brucellosis Vaccines is widely used in Cattle, Sheep and Other Animal. The most proportion of Brucellosis Vaccines is for Cattle with market share about 60 in 2016.
China is the largest supplier of Brucellosis Vaccines, with a production market share nearly 31% in 2016. Europe is the second largest supplier of Brucellosis Vaccines, enjoying production market share nearly 17% in 2016.
China is the largest consumption place, with a consumption market share nearly 31% in 2016. Following China, South America is the second largest consumption place with the consumption market share of 17%.
According to this study, over the next five years the Brucellosis Vaccines market will register a 3.8% CAGR in terms of revenue, the global market size will reach US$ 12 million by 2024, from US$ 10 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Brucellosis Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Brucellosis Vaccines market by product type, application, key manufacturers and key regions and countries.
This study considers the Brucellosis Vaccines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
S19 Vaccine
RB51 Vaccine Strain
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cattle
Sheep
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Brucellosis Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Brucellosis Vaccines market by identifying its various subsegments.
Focuses on the key global Brucellosis Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Brucellosis Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Brucellosis Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Brucellosis Vaccines Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Brucellosis Vaccines Consumption 2014-2024
- 2.1.2 Brucellosis Vaccines Consumption CAGR by Region
- 2.2 Brucellosis Vaccines Segment by Type
- 2.2.1 S19 Vaccine
- 2.2.2 RB51 Vaccine Strain
- 2.2.3 Other
- 2.3 Brucellosis Vaccines Consumption by Type
- 2.3.1 Global Brucellosis Vaccines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Brucellosis Vaccines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Brucellosis Vaccines Sale Price by Type (2014-2019)
- 2.4 Brucellosis Vaccines Segment by Application
- 2.4.1 Cattle
- 2.4.2 Sheep
- 2.4.3 Other
- 2.5 Brucellosis Vaccines Consumption by Application
- 2.5.1 Global Brucellosis Vaccines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Brucellosis Vaccines Value and Market Share by Application (2014-2019)
- 2.5.3 Global Brucellosis Vaccines Sale Price by Application (2014-2019)
3 Global Brucellosis Vaccines by Players
- 3.1 Global Brucellosis Vaccines Sales Market Share by Players
- 3.1.1 Global Brucellosis Vaccines Sales by Players (2017-2019)
- 3.1.2 Global Brucellosis Vaccines Sales Market Share by Players (2017-2019)
- 3.2 Global Brucellosis Vaccines Revenue Market Share by Players
- 3.2.1 Global Brucellosis Vaccines Revenue by Players (2017-2019)
- 3.2.2 Global Brucellosis Vaccines Revenue Market Share by Players (2017-2019)
- 3.3 Global Brucellosis Vaccines Sale Price by Players
- 3.4 Global Brucellosis Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Brucellosis Vaccines Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Brucellosis Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Brucellosis Vaccines by Regions
- 4.1 Brucellosis Vaccines by Regions
- 4.1.1 Global Brucellosis Vaccines Consumption by Regions
- 4.1.2 Global Brucellosis Vaccines Value by Regions
- 4.2 Americas Brucellosis Vaccines Consumption Growth
- 4.3 APAC Brucellosis Vaccines Consumption Growth
- 4.4 Europe Brucellosis Vaccines Consumption Growth
- 4.5 Middle East & Africa Brucellosis Vaccines Consumption Growth
5 Americas
- 5.1 Americas Brucellosis Vaccines Consumption by Countries
- 5.1.1 Americas Brucellosis Vaccines Consumption by Countries (2014-2019)
- 5.1.2 Americas Brucellosis Vaccines Value by Countries (2014-2019)
- 5.2 Americas Brucellosis Vaccines Consumption by Type
- 5.3 Americas Brucellosis Vaccines Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Brucellosis Vaccines Consumption by Countries
- 6.1.1 APAC Brucellosis Vaccines Consumption by Countries (2014-2019)
- 6.1.2 APAC Brucellosis Vaccines Value by Countries (2014-2019)
- 6.2 APAC Brucellosis Vaccines Consumption by Type
- 6.3 APAC Brucellosis Vaccines Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Brucellosis Vaccines by Countries
- 7.1.1 Europe Brucellosis Vaccines Consumption by Countries (2014-2019)
- 7.1.2 Europe Brucellosis Vaccines Value by Countries (2014-2019)
- 7.2 Europe Brucellosis Vaccines Consumption by Type
- 7.3 Europe Brucellosis Vaccines Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Brucellosis Vaccines by Countries
- 8.1.1 Middle East & Africa Brucellosis Vaccines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Brucellosis Vaccines Value by Countries (2014-2019)
- 8.2 Middle East & Africa Brucellosis Vaccines Consumption by Type
- 8.3 Middle East & Africa Brucellosis Vaccines Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Brucellosis Vaccines Distributors
- 10.3 Brucellosis Vaccines Customer
11 Global Brucellosis Vaccines Market Forecast
- 11.1 Global Brucellosis Vaccines Consumption Forecast (2019-2024)
- 11.2 Global Brucellosis Vaccines Forecast by Regions
- 11.2.1 Global Brucellosis Vaccines Forecast by Regions (2019-2024)
- 11.2.2 Global Brucellosis Vaccines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Brucellosis Vaccines Forecast by Type
- 11.8 Global Brucellosis Vaccines Forecast by Application
12 Key Players Analysis
- 12.1 Jinyu
- 12.1.1 Company Details
- 12.1.2 Brucellosis Vaccines Product Offered
- 12.1.3 Jinyu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Jinyu News
- 12.2 Colorado Serum
- 12.2.1 Company Details
- 12.2.2 Brucellosis Vaccines Product Offered
- 12.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Colorado Serum News
- 12.3 Boehringer Ingelheim
- 12.3.1 Company Details
- 12.3.2 Brucellosis Vaccines Product Offered
- 12.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Boehringer Ingelheim News
- 12.4 Biogenesis-Bago
- 12.4.1 Company Details
- 12.4.2 Brucellosis Vaccines Product Offered
- 12.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Biogenesis-Bago News
- 12.5 Vetal Company
- 12.5.1 Company Details
- 12.5.2 Brucellosis Vaccines Product Offered
- 12.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Vetal Company News
- 12.6 CZ Veterinaria
- 12.6.1 Company Details
- 12.6.2 Brucellosis Vaccines Product Offered
- 12.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 CZ Veterinaria News
- 12.7 SYVA Laboratorios
- 12.7.1 Company Details
- 12.7.2 Brucellosis Vaccines Product Offered
- 12.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 SYVA Laboratorios News
- 12.8 Indian Immunologicals
- 12.8.1 Company Details
- 12.8.2 Brucellosis Vaccines Product Offered
- 12.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Indian Immunologicals News
- 12.9 Qilu
- 12.9.1 Company Details
- 12.9.2 Brucellosis Vaccines Product Offered
- 12.9.3 Qilu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Qilu News
- 12.10 Tecnovax
- 12.10.1 Company Details
- 12.10.2 Brucellosis Vaccines Product Offered
- 12.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Tecnovax News
- 12.11 Hester Biosciences
- 12.12 Zoetis
- 12.13 Onderstepoort Biological
- 12.14 Instituto Rosenbusch
- 12.15 Ceva Sante Animale
- 12.16 Calier & Biologicos Laverlam
- 12.17 Biovet
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Brucellosis Vaccines . Industry analysis & Market Report on Brucellosis Vaccines is a syndicated market report, published as Global Brucellosis Vaccines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Brucellosis Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
